Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Roel G.W. Verhaak(Broad Institute), Katherine A. Hoadley(University of North Carolina at Chapel Hill), Elizabeth Purdom(University of California, Berkeley), Victoria Wang(University of California, Berkeley), Yuan Qi(University of North Carolina at Chapel Hill), Matthew D. Wilkerson(University of North Carolina at Chapel Hill), C. Ryan Miller(University of North Carolina at Chapel Hill), Li Ding(Washington University in St. Louis), Todd R. Golub(Broad Institute), Jill P. Mesirov(Broad Institute), Gabriele Alexe(Broad Institute), Michael S. Lawrence(Broad Institute), Michael O'Kelly(Broad Institute), Pablo Tamayo(Broad Institute), Barbara A. Weir(Broad Institute), Stacey Gabriel(Broad Institute), Wendy Winckler(Broad Institute), Supriya Gupta(Broad Institute), Lakshmi R. Jakkula(Lawrence Berkeley National Laboratory), Heidi S. Feiler(Lawrence Berkeley National Laboratory), John Hodgson(University of California, San Francisco), C. David James(University of California, San Francisco), Jann N. Sarkaria(Mayo Clinic), Cameron Brennan(Memorial Sloan Kettering Cancer Center), A Kahn(SRA International (United States)), Paul T. Spellman(Lawrence Berkeley National Laboratory), Richard K. Wilson(Washington University in St. Louis), Terence P. Speed(Walter and Eliza Hall Institute of Medical Research), Joe W. Gray(Lawrence Berkeley National Laboratory), Matthew Meyerson(Broad Institute), Gad Getz(Broad Institute), Charles M. Perou(University of North Carolina at Chapel Hill), D. Neil Hayes(University of North Carolina at Chapel Hill)
Cancer Cell
January 1, 2010
Cited by 7,719Open Access
Full Text

Abstract


Related Papers